Companies: 10,795·Total market cap: $144.5T
Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc.

DNTHNASDAQHealthcare● Active
$81.22
+$0.71(+0.88%)
Market Cap$3.4B
P/E Ratio—
52W High$96.5
52W Low$16.64
Overview

Dianthus Therapeutics, Inc. (DNTH) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · DNTH · as of Mar 9, 2026

Latest filing snapshot

11
-67-85.90%vs prior year

Dianthus Therapeutics, Inc. (DNTH) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
11
Change (1Y)
-67
Growth % (1Y)
-85.90%
Revenue / Employee
$185.1K
Net Income / Employee
$-14.76M
Market Cap
$3.4B

DNTH Employee Count

2023 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-0911-67-85.90%
2025-03-1178+25+47.17%
2024-03-2153——

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Immatics N.V.
IMTX
Immatics N.V.
554#2
AnaptysBio, Inc.
ANAB
AnaptysBio, Inc.
136#3
Atai Beckley Inc.
ATAI
Atai Beckley Inc.
99#4
BridgeBio Oncology Therapeutics Inc.
BBOT
BridgeBio Oncology Therapeutics Inc.
62#5
Enliven Therapeutics, Inc.
ELVN
Enliven Therapeutics, Inc.
62#6
Nektar Therapeutics
NKTR
Nektar Therapeutics
61#7
Dianthus Therapeutics, Inc.
DNTH
Dianthus Therapeutics, Inc.YOU
11
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · DNTH peer comparison

About DNTH employees

DNTH Employees · Headcount

Dianthus Therapeutics, Inc. (DNTH) employee data is sourced from the annual SEC 10-K filing. As of 2025, Dianthus Therapeutics, Inc. had 11 full-time employees globally. Full-time employees only. Global consolidated headcount.

Dianthus Therapeutics, Inc. employs 11 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $185,091, reflecting the company's operational efficiency.

Dianthus Therapeutics, Inc.'s workforce decreased by 67 (85.90%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Dianthus Therapeutics, Inc.'s revenue per employee of $185,091 positions it among the notable performers in the Biotechnology sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

DNTH Employees · 5 questions

As of the latest SEC 10-K filing (2025), Dianthus Therapeutics, Inc. had 11 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Dianthus Therapeutics, Inc. employee counthow many employees does Dianthus Therapeutics, Inc. haveDNTH total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-09